SINGAPORE BIO-INNOVATIONS
Singapore Bio-Innovations is a venture capital firm that finances later stage investments.
SINGAPORE BIO-INNOVATIONS
Status:
Active
Similar Organizations
Daiwa SMBC Capital
Daiwa SMBC Capital is a venture capital firm that finances later stage and private equity investments.
DTU Innovation
DTU Innovation is a venture capital firm that finances seed stage investments.
Pennstro Ventures
Pennstro Ventures is a venture capital firm that finances early stage investments.
The Viking Club
The Viking Club is a micro venture capital that finances later-stage investments.
Wallington Investments
Wallington Investments is a venture capital firm that finances early and later stage investments.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-12-22 | Humanigen | Singapore Bio-Innovations investment in Series D - Humanigen | 12 M USD |
| 2008-09-23 | Humanigen | Singapore Bio-Innovations investment in Series D - Humanigen | 20 M USD |
| 2007-08-03 | Humanigen | Singapore Bio-Innovations investment in Series C - Humanigen | 20 M USD |
| 2005-03-16 | Humanigen | Singapore Bio-Innovations investment in Series B - Humanigen | 20 M USD |
| 2005-02-08 | Five Prime Therapeutics | Singapore Bio-Innovations investment in Venture Round - Five Prime Therapeutics | 45 M USD |
| 2001-10-09 | Aderis Pharmaceuticals | Singapore Bio-Innovations investment in Series D - Aderis Pharmaceuticals | 45 M USD |
More informations about "Singapore Bio-Innovations"
BioPIPS Consortium In Singapore Expands Membership
Mar 18, 2024 BioNTech, GSK, Sanofi, NTU, NTUitive, NUS and SIT signed a membership agreement on 15 March 2024 to join the Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium led by A*STAR and …See details»
Singapore Bio-Innovations - Crunchbase
Singapore Bio-Innovations is a venture capital firm that finances later stage investments. Singapore, Central Region, Singapore; Venture Capital Late Stage Venture 132,267; ... 226 …See details»
Global pharma giants partner Singapore researchers to …
Dec 6, 2022 SINGAPORE – Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); …See details»
MEDIA RELEASE FOR IMMEDIATE RELEASE Global pharma giants …
Sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology …See details»
BioPIPS Consortium In Singapore Expands Membership, Seeks To …
The company joins global pharmaceutical companies GSK and Sanofi alongside Singapore’s research organisations and institutes of higher learning Agency for Science, Technology and …See details»
Biopips Consortium In Singapore Expands …
The Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium has been expanded with the addition of global immunotherapy company, BioNTech. The company joins global pharmaceutical companies GSK and …See details»
BioNTech Amplifies Singapore's Biopharma Innovation …
Mar 18, 2024 BioNTech, GSK, Sanofi, NTU, NTUitive, NUS and SIT signed a membership agreement on 15 March 2024 to join the Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium led by A*STAR and …See details»
Pharma giants partner with Singapore researchers to …
BioPIPS seeks to use research and innovation to grow Singapore's manufacturing capabilities for biologics, which include recombinant therapeutic proteins, and vaccines. The consortium will bring together leading industry experts and …See details»
BioNTech joins Biologics Pharma Innovation Programme …
Mar 18, 2024 The consortium, led by A*STAR, aims to increase productivity and sustainability in biologics manufacturing, transforming the existing base of biologics production in Singapore.See details»
Singapore Bio-Innovations - BioCentury Company Profiles - BCIQ
Singapore Bio-Innovations - BioCentury Company Profiles for the biopharma industrySee details»
Singapore Bio-Innovations - Investments, Portfolio & Company Exits
Dec 22, 2008 Kalobios Pharmaceuticals, Inc. KaloBios Pharmaceuticals is a biotechnology company that develops advancing medicines for patients. Singapore Bio-Innovations is a …See details»
Biomedical Sciences Industry Partnership Office, Singapore …
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
Why Singapore is a top choice for biopharma firms seeking global ...
Oct 20, 2023 “Besides robust infrastructure and a highly-skilled talent pool, Singapore is very stable politically and economically. The business environment is highly transparent, and the …See details»
6 Biotech Companies in Singapore to Know
Apr 3, 2024 At the turn of the century, Singapore set out to become a world-class biotech hub, introducing a government initiative that led to the construction of the Biopolis research and …See details»
Biotech incubator Flagship Pioneering opens regional office in …
Nov 8, 2023 “There is a lot of science and innovation happening here through programmes by the Agency for Science, Technology and Research as well as support from Singapore’s …See details»
Biomedical Sciences Industry Partnership Office, Singapore - BIO ...
Jun 5, 2023 Singapore is an emerging global biotech innovation hub, fostering groundbreaking advancements and transformative solutions in biotech and healthcare.See details»
Singapore’s biotech scene: six companies leading the way
Oct 17, 2023 Singapore set out to become a global biotech hub back in 2000, and, although still awaiting its big success story in the industry, it is currently a leading hub in the APAC region …See details»
Singapore’s biomedical cluster: Lessons from two decades of …
Feb 19, 2021 In 2000, the Singaporean government launched a strategy to develop a biomedical industry within Singapore, and in late 2003 it launched Biopolis, a purpose-built campus, which …See details»
A cell biological perspective on Singapore’s scientific growth
Jan 23, 2023 WH: As part of the government’s ambitious plan to invest in biomedical sciences, Singapore’s first life sciences institute — the IMCB — was launched in 1985 and is now one of …See details»
Innovation in a crisis: Singapore flexes biomed chops in the fight ...
Sep 4, 2020 From prevention to cure, Singapore builds upon a strong biomedical foundation and a diverse innovation ecosystem to take on COVID-19. Public and private players have been …See details»